Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA193201, AI 132164, CA193939, AI125859
NCI NIH HHS
Grant: R01 CA193939
NIAID NIH HHS
Grant: U01 AI125859
NIAID NIH HHS
Grant: T32 AI132164
National Institutes of Health
Grant: 5T32CA193201-05
Integrative Training in Oncogenic Signaling
National Institutes of Health
Grant: 7U01AI125859-06
Extrinsic and intrinsic factors regulating commensal-specific T helper-17 cells
National Institutes of Health
Grant: 5R01CA193939-02
Mechanism of gp96/grp94 in regulating plasma cells and myeloma
National Institutes of Health
Grant: 1T32AI132164-01
Program in Immunology Research and Entrepreneurship (PIRE)
FWCI
3.17
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals